Methocarbamol (Page 2 of 2)

Treatment

Management of overdose includes symptomatic and supportive treatment. Supportive measures include maintenance of an adequate airway, monitoring urinary output and vital signs, and administration of intravenous fluids if necessary. The usefulness of hemodialysis in managing overdose is unknown.

DOSAGE AND ADMINISTRATION

Methocarbamol Tablets USP, 500 mg – Adults:

Initial dosage: 3 tablets q.i.d.

Maintenance dosage: 2 tablets q.i.d.

Methocarbamol Tablets USP, 750 mg – Adults:

Initial dosage: 2 tablets q.i.d.

Maintenance dosage: 1 tablet q.4h. or 2 tablets t.i.d.

Six grams a day are recommended for the first 48 to 72 hours of treatment. (For severe conditions 8 grams a day may be administered). Thereafter, the dosage can usually be reduced to approximately 4 grams a day.

HOW SUPPLIED

Methocarbamol Tablets, USP, 500 mg are white, round, bisected tablets, debossed with LAN over 1302, supplied in bottles of 100 and 500 tablets.

100 Tablets NDC 0527-1302-01

500 Tablets NDC 0527-1302-05

Methocarbamol Tablets, USP, 750 mg are white, scored, capsule-shaped tablets debossed with LAN besides 1152, supplied in bottles of 100 and 500 tablets.

100 Tablets NDC 0527-1152-01

500 Tablets NDC 0527-1152-05

Store at controlled room temperature, between 20°C and 25°C (68°F and 77°F) [see USP Controlled Room Temperature].

Dispense in a tight container as defined in the USP with a child-resistant closure (as required).

MANUFACTURED BY
LANNETT CO., INC.
PHILADELPHIA, PA 19136

Revised 01/07

METHOCARBAMOL
methocarbamol tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0527-1302
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Methocarbamol (Methocarbamol) Methocarbamol 500 mg
Inactive Ingredients
Ingredient Name Strength
acacia
calcium stearate
colloidal silicon dioxide
corn starch
croscarmellose sodium
methylcellulose
Product Characteristics
Color WHITE Score 2 pieces
Shape ROUND Size 13mm
Flavor Imprint Code LAN;1302
Contains
Coating false Symbol false
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0527-1302-01 100 TABLET (100 TABLET) in 1 BOTTLE None
2 NDC:0527-1302-05 500 TABLET (500 TABLET) in 1 BOTTLE None
METHOCARBAMOL
methocarbamol tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0527-1152
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Methocarbamol (Methocarbamol) Methocarbamol 750 mg
Inactive Ingredients
Ingredient Name Strength
acacia
calcium stearate
colloidal silicon dioxide
corn starch
croscarmellose sodium
methylcellulose
Product Characteristics
Color WHITE Score 2 pieces
Shape OVAL (capsule shaped) Size 19mm
Flavor Imprint Code LAN;1152
Contains
Coating false Symbol false
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0527-1152-01 100 TABLET (100 TABLET) in 1 BOTTLE None
2 NDC:0527-1152-05 500 TABLET (500 TABLET) in 1 BOTTLE None
Labeler — Lannett Company, Inc.

Revised: 06/2007 Lannett Company, Inc.

Page 2 of 2 1 2

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.